This is usually followed by injections every three or four days for the next two to three weeks
The species results of these two methods were cross-compared and a result was only considered definitive if it was identified using both methodologies
The diagnostic process typically involves: Clinical history taking, focusing on symptoms (fatigue, neurological changes, dietary habits) Physical examination for signs of anaemia or neurological impairment Blood tests including full blood count, serum B12, and often folate levels Additional investigations such as intrinsic factor antibodies or parietal cell antibodies if pernicious anaemia is suspected For borderline results, additional tests like holotranscobalamin (active B12) may be considered NICE guidance recommends that treatment should commence based on clinical presentation if neurological symptoms are present, without waiting for laboratory confirmation, as delays can result in irreversible nerve damage
Your provider will personalize your care plan and adjust your injection schedule as needed
Signal sensitivity pulsed dosing is the conservative way to avoid blunting the response over time
Baseline laboratory testing before starting the peptide might include comprehensive metabolic panel, lipid profile, glucose and insulin levels, thyroid function, and body composition analysis